207 related articles for article (PubMed ID: 30829920)
1. Identifying Clonal Origin of Multifocal Hepatocellular Carcinoma and Its Clinical Implications.
Xie DY; Fan HK; Ren ZG; Fan J; Gao Q
Clin Transl Gastroenterol; 2019 Feb; 10(2):e00006. PubMed ID: 30829920
[TBL] [Abstract][Full Text] [Related]
2. Emerging biomolecules for practical theranostics of liver hepatocellular carcinoma.
Hu M; Xia X; Chen L; Jin Y; Hu Z; Xia S; Yao X
Ann Hepatol; 2023; 28(6):101137. PubMed ID: 37451515
[TBL] [Abstract][Full Text] [Related]
3. The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapy.
Knudsen ES; Gopal P; Singal AG
Am J Pathol; 2014 Mar; 184(3):574-83. PubMed ID: 24388934
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant Therapy for Hepatocellular Carcinoma After Curative Treatment: Several Unanswered Questions.
Li L; Li ZZ; Pan LX; Su JY; Huang S; Ma L; Zhong JH
J Clin Transl Hepatol; 2024 May; 12(5):525-533. PubMed ID: 38779519
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma-the role of the underlying liver disease in clinical practice.
de Mattos AZ; Bombassaro IZ; Vogel A; Debes JD
World J Gastroenterol; 2024 May; 30(19):2488-2495. PubMed ID: 38817660
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapies after curative treatments for hepatocellular carcinoma: Current status and prospects.
Zhu XD; Li KS; Sun HC
Genes Dis; 2020 Sep; 7(3):359-369. PubMed ID: 32884990
[TBL] [Abstract][Full Text] [Related]
7. The Current and Prospective Adjuvant Therapies for Hepatocellular Carcinoma.
Du JS; Hsu SH; Wang SN
Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611100
[TBL] [Abstract][Full Text] [Related]
8. Injectable Hydrogels Including Magnetic Nanosheets for Multidisciplinary Treatment of Hepatocellular Carcinoma via Magnetic Hyperthermia.
Gong J; Hu J; Yan X; Xiang L; Chen S; Yang H; Chen Z; Hou Q; Song Y; Xu Y; Liu D; Ji C; Qin Q; Sun H; Peng J; Cao B; Lu Y
Small; 2024 Jan; 20(3):e2300733. PubMed ID: 37452437
[TBL] [Abstract][Full Text] [Related]
9. NMFBFS: A NMF-Based Feature Selection Method in Identifying Pivotal Clinical Symptoms of Hepatocellular Carcinoma.
Ji Z; Meng G; Huang D; Yue X; Wang B
Comput Math Methods Med; 2015; 2015():846942. PubMed ID: 26579207
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma.
Dong LQ; Peng LH; Ma LJ; Liu DB; Zhang S; Luo SZ; Rao JH; Zhu HW; Yang SX; Xi SJ; Chen M; Xie FF; Li FQ; Li WH; Ye C; Lin LY; Wang YJ; Wang XY; Gao DM; Zhou H; Yang HM; Wang J; Zhu SD; Wang XD; Cao Y; Zhou J; Fan J; Wu K; Gao Q
J Hepatol; 2020 May; 72(5):896-908. PubMed ID: 31887370
[TBL] [Abstract][Full Text] [Related]
11. Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma.
Xu LX; He MH; Dai ZH; Yu J; Wang JG; Li XC; Jiang BB; Ke ZF; Su TH; Peng ZW; Guo Y; Chen ZB; Chen SL; Peng S; Kuang M
Ann Oncol; 2019 Jun; 30(6):990-997. PubMed ID: 30916311
[TBL] [Abstract][Full Text] [Related]
12. 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights.
Xie DY; Ren ZG; Zhou J; Fan J; Gao Q
Hepatobiliary Surg Nutr; 2020 Aug; 9(4):452-463. PubMed ID: 32832496
[TBL] [Abstract][Full Text] [Related]
13. Hepatocytes direct the formation of a pro-metastatic niche in the liver.
Lee JW; Stone ML; Porrett PM; Thomas SK; Komar CA; Li JH; Delman D; Graham K; Gladney WL; Hua X; Black TA; Chien AL; Majmundar KS; Thompson JC; Yee SS; O'Hara MH; Aggarwal C; Xin D; Shaked A; Gao M; Liu D; Borad MJ; Ramanathan RK; Carpenter EL; Ji A; de Beer MC; de Beer FC; Webb NR; Beatty GL
Nature; 2019 Mar; 567(7747):249-252. PubMed ID: 30842658
[TBL] [Abstract][Full Text] [Related]
14. Research Progress on the Anti-Cancer Molecular Mechanisms of Huaier.
Qi T; Dong Y; Gao Z; Xu J
Onco Targets Ther; 2020; 13():12587-12599. PubMed ID: 33335400
[TBL] [Abstract][Full Text] [Related]
15. Huaier Suppresses the Hepatocellular Carcinoma Cell Cycle by Regulating Minichromosome Maintenance Proteins.
Niu Y; Shan L; Gao H; Zhang C; Qian Z; Wang Z; Xu X; Zhang X; Wang J; Ma L; Chen L; Yu Y
Onco Targets Ther; 2020; 13():12015-12025. PubMed ID: 33244243
[TBL] [Abstract][Full Text] [Related]
16. A novel focal adhesion related gene signature for prognostic prediction in hepatocellular carcinoma.
Lin Z; Miao D; Xu Q; Wang X; Yu F
Aging (Albany NY); 2021 Apr; 13(7):10724-10748. PubMed ID: 33850056
[TBL] [Abstract][Full Text] [Related]
17. Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib.
Yang Y; Sun M; Yao W; Wang F; Li X; Wang W; Li J; Gao Z; Qiu L; You R; Yang C; Ba Q; Wang H
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32179631
[TBL] [Abstract][Full Text] [Related]
18. Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma.
Gao Q; Zhu H; Dong L; Shi W; Chen R; Song Z; Huang C; Li J; Dong X; Zhou Y; Liu Q; Ma L; Wang X; Zhou J; Liu Y; Boja E; Robles AI; Ma W; Wang P; Li Y; Ding L; Wen B; Zhang B; Rodriguez H; Gao D; Zhou H; Fan J
Cell; 2019 Oct; 179(2):561-577.e22. PubMed ID: 31585088
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant treatment strategy after curative resection for hepatocellular carcinoma.
Zhang W; Zhang B; Chen XP
Front Med; 2021 Apr; 15(2):155-169. PubMed ID: 33754281
[TBL] [Abstract][Full Text] [Related]
20. Identification of immune-related target and prognostic biomarkers in PBMC of hepatocellular carcinoma.
Hu R; Zhang W; Han Z; Ma M; Huang Q; Lv M; Ma W; Sun X; Feng W; Li J; Zhong X; Sun J; Yao W; Zhou X
BMC Gastroenterol; 2023 Jul; 23(1):234. PubMed ID: 37438735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
